March 17, 2019 Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA
C-Path, FNIH Announce Clinical Development User’s Guide for Kidney Safety Biomarkers TUCSON, Ariz., March 14, 2019 — The Critical Path Institute’s (C-Path) Predictive Safety Testing Consortium (PST
March 10, 2019 Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth
C-Path and FARA Launch Friedreich’s Ataxia Integrated Clinical Database to Advance the Development of Treatments for FA TUCSON, Ariz. and DOWNINGTOWN, Penn., February 27, 2019 — Critical Path Institute’s (C-Path) Data Collaboration Center (DCC) a
February 23, 2019 Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies
February 19, 2019 Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA
February 8, 2019 Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders
April 24, 2019-April 25, 2019 Tenth Annual Patient-Reported Outcome Consortium Workshop WHAT: Tenth Annual Patient-Reported Outcome Consortium Workshop WHEN: April 24-25, 2019 WHERE: Sheraton Silver Sprin